The Human Immunodeficiency Virus (HIV) Diagnosis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of HIV diagnosis has experienced significant growth lately. It is expected to rise from $4.2 billion in 2024 to a projected $4.68 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.4%.
The market for Human Immunodeficiency Virus (HIV) diagnosis is projected to reach $7.12 billion in 2029, with a compound annual growth rate (CAGR) of 11.0%.
Download Your Free Sample of the 2025 Human Immunodeficiency Virus (HIV) Diagnosis Market Report and Uncover Key Trends Now!The drivers in the human immunodeficiency virus (hiv) diagnosis market are:
• Expansion of voluntary counselling and testing services
• Development and improvements in HIV antibody tests
• The ongoing HIV/AIDS epidemic fuelling increased demand
• Rise of community-led and peer-led initiatives conducting HIV testing
The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented –
1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions
The trends in the human immunodeficiency virus (hiv) diagnosis market are:
• Advancements in testing technologies are shaping the future of the HIV diagnosis market.
• The market is significantly influenced by the focus on targeted testing strategies.
• Community-based testing and outreach is emerging as a key trend.
• The emphasis on equity, inclusivity, policy, and funding priorities are defining the future trends in the market.
The major players in the human immunodeficiency virus (hiv) diagnosis market are:
• Thermo Fisher Scientific Inc.
North America was the largest region in the HIV diagnosis market in 2023